Krystal Biotech, Inc. (KRYS) financial statements (2020 and earlier)

Company profile

Business Address 2100 WHARTON STREET
PITTSBURGH, PA 15203
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:19450
Cash and cash equivalents18850
Short-term investments6 
Other undisclosed cash, cash equivalents, and short-term investments0 
Prepaid expense 0
Other current assets 0
Other undisclosed current assets2 
Total current assets:19650
Noncurrent Assets
Operating lease, right-of-use asset3
Property, plant and equipment80
Long-term investments and receivables0 
Long-term investments0 
Other noncurrent assets1 
Total noncurrent assets:130
TOTAL ASSETS:20950
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10
Accounts payable10
Accrued liabilities00
Debt0 
Other liabilities0 
Other undisclosed current liabilities20
Total current liabilities:31
Noncurrent Liabilities
Long-term debt and lease obligation3 
Operating lease, liability3
Total noncurrent liabilities:3 
Total liabilities:61
Stockholders' equity
Stockholders' equity attributable to parent20349
Additional paid in capital24259
Accumulated other comprehensive income0 
Accumulated deficit(39)(9)
Total stockholders' equity:20349
TOTAL LIABILITIES AND EQUITY:20950

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2017
Operating expenses(22)(5)
Other undisclosed operating income0 
Operating loss:(22)(5)
Nonoperating expense (3)
Net loss:(22)(8)
Other undisclosed net income attributable to parent3 
Net loss available to common stockholders, diluted:(19)(8)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2017
Net loss:(22)(8)
Comprehensive loss:(22)(8)
Other undisclosed comprehensive income, net of tax, attributable to parent3 
Comprehensive loss, net of tax, attributable to parent:(19)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: